EGFR and chronic kidney disease: Activation of proproliferative signaling pathways of mTOR, TGF-α-EGFR, NF-κB and Cox-PGE, together with interruption of cell division gatekeepers such as p21, lead to parathyroid cell proliferation in CKD.